Overview
Zhongkai Tong practices practicing medicine in Ningbo, China.
Their clinical expertise encompasses Pulmonary Fibrosis, Osteolysis Syndrome Recessive, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
They are actively involved in clinical research, co-authoring 15 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Zhongkai D. Tong
Is Zhongkai D. Tong a top-rated expert for Pulmonary Fibrosis?
MediFind is an objective health platform that identifies experts based on real-world data. Zhongkai D. Tong is classified as an Experienced expert for Pulmonary Fibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Zhongkai D. Tong participate in research or clinical trials?
Yes. Zhongkai D. Tong has published 15 articles and abstracts on conditions like Pulmonary Fibrosis. You can view a list of Zhongkai D. Tong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung AdenocarcinomaTong isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerTong isExperienced. Learn about Lung Cancer.
- Osteolysis Syndrome Recessive
- Pulmonary FibrosisTong isExperienced. Learn about Pulmonary Fibrosis.
- Small Cell Lung Cancer (SCLC)